French microbiologist Emmanuelle Charpentier, who was named a co-winner of the second Tang Prize in biopharmaceutical science on Sunday for her work in the development of CRISPR/Cas9, said she hopes the genome editing technology can be used to treat currently incurable conditions.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Cabinet approves laws to more robustly protect undersea cables, pipes
09/18/2025 06:59 PM - Business
Linkou power plant unit back online next week: Vice Economic Minister
09/18/2025 06:47 PM - Society
Ex-WDA branch chief sentenced to 4 years, 6 months for corruption
09/18/2025 06:34 PM - Business
Central bank leaves interest rates unchanged for 6th straight quarter
09/18/2025 05:37 PM - Politics
Legislator, former Taipei mayor attend KMT chair election registration
09/18/2025 05:31 PM